• Home
  1. Home
  2. Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report
Scientific article
Case report
OA Policy
English

Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report

ContributorsVionnet, Julien; Pascual, Manuel Antonio; Chtioui, Haithem; Giostra, Emiliano; Majno, Pietro; Decosterd, Laurent; Moradpour, Darius
Published inBMC gastroenterology, vol. 15, no. 1, 38
Publication date2015
Abstract

Recurrent hepatitis C virus infection after liver transplantation is associated with reduced graft and patient survival. Re-transplantation for graft failure due to recurrent hepatitis C is controversial and not performed in all centers.

Keywords
  • Directly acting antiviral
  • Hepatitis C virus
  • Liver transplantation
  • Therapeutic drug monitoring
Affiliation entities
Research groups
Citation (ISO format)
VIONNET, Julien et al. Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report. In: BMC gastroenterology, 2015, vol. 15, n° 1, p. 38. doi: 10.1186/s12876-015-0259-5
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Additional URL for this publicationhttp://www.biomedcentral.com/1471-230X/15/38
Journal ISSN1471-230X
755views
297downloads

Technical informations

Creation13/05/2015 14:31:00
First validation13/05/2015 14:31:00
Update time14/03/2023 23:18:27
Status update14/03/2023 23:18:26
Last indexation31/10/2024 00:17:15
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack